ERNA · Insider Trading
Ernexa Therapeutics Inc. Common Stock
Every open-market purchase and sale reported by ERNA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | David Polinsky | Director | A | +5,083 deriv. | — |
| 2026-09-01 | Peter Cicala | Director | A | +11,026 deriv. | — |
| 2026-09-01 | Sanjeev Luther | President and CEO | A | +118,848 deriv. | — |
| 2026-09-01 | William A. Wexler | Director | A | +5,943 deriv. | — |
| 2026-09-01 | Elena Ratner | Director | A | +5,944 deriv. | — |
| 2026-09-01 | James Arthur Bristol | Director | A | +13,403 deriv. | — |
| 2025-07-07 | Sandra M Gurrola | Sr. VP of Finance | M | +30 | — |
| 2025-06-11 | Charles Cherington | 10%+ Owner | Buy | +21,241,163 | +$2.22M |
| 2025-05-07 | Charles Cherington | 10%+ Owner | Buy | +13,252,112 | — |
| 2025-04-04 | Charles Cherington | 10%+ Owner | Buy | +3,768,397 | +$394.17K |
| 2025-02-10 | Sanjeev Luther | President & CEO | A | +1,123,350 deriv. | — |
| 2025-02-10 | James Arthur Bristol | Director | A | +72,074 deriv. | — |
| 2025-02-10 | William A. Wexler | Director | A | +124,533 deriv. | — |
| 2025-02-10 | Peter Cicala | Director | A | +51,485 deriv. | — |
| 2025-02-10 | Sandra M Gurrola | Sr. VP of Finance | A | +150,000 deriv. | — |
| 2025-01-14 | Elena Ratner | Director | A | +140,078 deriv. | — |
| 2024-11-05 | Charles Cherington | 10%+ Owner | MIXED | +16,071,658 | +$1.41M |
| 2024-06-25 | Sandra M Gurrola | Sr. VP of Finance | MIXED | +257 | −$349 |
| 2024-04-29 | Peter Cicala | Director | A | +88,946 deriv. | — |
| 2024-04-29 | James Arthur Bristol | Director | A | +124,525 deriv. | — |
| 2024-04-29 | Sandra M Gurrola | Sr. VP of Finance | A | +80,000 deriv. | — |
| 2024-01-03 | Dorothy J Clarke | General Counsel | A | +168,521 deriv. | — |
| 2024-01-03 | Sanjeev Luther | President and CEO | A | +1,685,218 deriv. | — |
| 2023-12-20 | Charles Cherington | 10%+ Owner | MIXED | +3,125,976 deriv. | — |
| 2023-12-18 | Freebird Investments LLC | 10%+ Owner | MIXED | +10,385,376 deriv. | — |
| 2023-08-25 | Charles Cherington | 10%+ Owner | Buy | +2,307,692 deriv. | — |
| 2023-07-18 | Richard W Wagner | Director | Buy | +83,916 deriv. | — |
| 2023-07-18 | Freebird Investments LLC | 10%+ Owner | Buy | +2,360,133 deriv. | — |
| 2023-07-18 | Brant Binder | Director | Buy | +83,916 deriv. | — |
| 2023-06-23 | Sandra M Gurrola | Vice President of Finance | MIXED | +259 | −$444 |
| 2023-01-13 | Matthew Angel | President and CEO | A | +132,003 deriv. | — |
| 2022-12-06 | Charles Cherington | Director | Buy | +261,756 | +$858.56K |
| 2022-12-06 | Nicholas Jason Singer | Director | Buy | +283,286 | +$929.18K |
| 2022-12-05 | John D Halpern | 10%+ Owner | Buy | +335,920 | +$1.10M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Charles Cherington | 10%+ Owner | 111,093 | $215.30K |
| Sandra M Gurrola | Sr. VP of Finance | 4 | $8 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ERNA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.